We retrospectively identified 163 patients with inoperable NSCLC and sufficient tumor tissue for ERCC1 analysis, who had received carboplatin and gemcitabine as first-line treatment.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback